Changeflow GovPing Pharma & Drug Safety Controlled Substances Importer Application - Re...
Routine Notice Added Draft

Controlled Substances Importer Application - Research Triangle Institute

Favicon for www.regulations.gov Regs.gov: Drug Enforcement Administration
Published
Detected
Email

Summary

DEA published notice that Research Triangle Institute (Durham, NC) applied to be registered as an importer of controlled substances for 30 Schedule I drug classes including synthetic cathinones, benzodiazepine analogs, and other psychoactive substances. The application was filed March 3, 2026. Interested parties may submit comments or request hearings on the application through May 1, 2026.

What changed

DEA published notice that Research Triangle Institute applied for registration as a controlled substances importer under 21 CFR 1301.34(a). The application covers 30 Schedule I controlled substance classes including drug codes 1219-1595 (amines, cathinones, phenethylamines, benzodiazepine analogs, and other synthetic psychoactive substances) listed in the attached schedule.

Any registered bulk manufacturers of these controlled substance classes or applicants may submit electronic comments or written objections to the proposed registration, or request a hearing on the application, by May 1, 2026. Requests for hearing must be sent to the Hearing Clerk/OALJ and DEA Federal Register Representative at the Springfield, Virginia address. This is a routine notice of application; no immediate compliance obligations are created for third parties.

What to do next

  1. Submit electronic comments through regulations.gov if you have objections to the importer registration application
  2. File written request for hearing if you wish to formally contest the application
  3. Ensure your comments reference DEA docket DEA-2026-0531

Archived snapshot

Apr 2, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Content

ACTION:

Notice of application.

SUMMARY:

Research Triangle Institute has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer
to
SUPPLEMENTARY INFORMATION
listed below for further drug information.

DATES:

Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on,
or objections to the issuance of the proposed registration on or before May 1, 2026. Such persons may also file a written
request for a hearing on the application on or before May 1, 2026.

ADDRESSES:

The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file
for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive
a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit
the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ,
8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration,
Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION:

In accordance with 21 CFR 1301.34(a), this is notice that on March 3, 2026, Research Triangle Institute, 3040 East Cornwallis
Road, Hermann Building, Room 106, Durham, North Carolina 27713, applied to be registered as an importer of the following basic
class(es) of controlled substance(s):

Controlled substance Drug code Schedule
Amineptine (7-[(10,11-dihydro-5Hdibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) 1219 I
Mesocarb (N-phenyl-N′-(3-(1-phenylpropan-2-yl)-1,2,3- oxadiazol-3-ium-5-yl)carbamimidate) 1227 I
3-Fluoro-N-methylcathinone (3-FMC) 1233 I
Cathinone 1235 I
Methcathinone 1237 I
4-Fluoro-N-methylcathinone (4-FMC) 1238 I N 1238 I
Para-Methoxymethamphetamine (PMMA), 1-(4- methoxyphenyl)-N-methylpropan-2-amine 1245 I
Pentedrone (α-methylaminovalerophenone) 1246 I
Mephedrone (4-Methyl-N-methylcathinone) 1248 I
4-Methyl-N-ethylcathinone (4-MEC) 1249 I
Naphyrone 1258 I
3-methylmethcathinone (2-(methylamino)-1-(3- methylphenyl)propan-1-one) 1259 I
N-Ethylamphetamine 1475 I
Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2- amine) 1478 I N 1478 I
N,N-Dimethylamphetamine 1480 I
Fenethylline 1503 I
Aminorex 1585 I
4-Methylaminorex (cis isomer) 1590 I
4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4- 1595 I N methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5- (4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine) 1595 I
Ethylphenidate 1727 I
Gamma Hydroxybutyric Acid 2010 I
Methaqualone 2565 I
Mecloqualone 2572 I
Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6Hthieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine 2780 I
Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4Hbenzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) 2785 I
Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4Hbenzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine 2786 I
Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine 2788 I
Diclazepam (7-chloro-5-(2-chloro-5-(2-chlorophenyl)-1- methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one 2789 I
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) 6250 I
SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) 7008 I
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) 7010 I
5-Fluoro-UR-144 and XLR11 1-(5-Fluoro-pentyl)1H-indol-3-ylmethanone 7011 I
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) 7012 I
FUB-144 (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) 7014 I
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) 7019 I
MDMB-FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) 7020 I
FUB-AMB, MMB- FUBINACA, AMB-FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate) 7021 I
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) 7023 I
THJ-2201 (1-(5-fluoropentyl)-1H-indazol-3-ylmethanone) 7024 I
5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluropentyl)-1H-indazole-3-carboximide) 7025 I
ADB-BUTINACA (N-(1-amino-3,3-dimethyl-1-oxobutan 2-yl)-1-butyl-1H-indazole-3-carboxamide) 7027 I
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) 7031 I
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) 7032 I
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) 7033 I
5F-ADB, 5F-MDMB-PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) 7034 I
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) 7035 I
5F-EDMB-PINACA (ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) 7036 I
5F-MDMB-PICA (methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) 7041 I
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) 7042 I
4F-MDMB-BINACA (4F-MDMB-BUTINACA or methyl 2- (1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3- dimethylbutanoate) 7043 I
N 7043 I
MMB-CHMICA, AMB-CHMICA (methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate) 7044 I
FUB-AKB48, FUB-APINACA, AKB48 N-(4-FLUOROBENZYL) (N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboximide) 7047 I
APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide) 7048 I
5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) 7049 I
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) 7081 I
5F-CUMYL-PINACA, 5GT-25 (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide) 7083 I
5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide) 7085 I
4-CN-CUML-BUTINACA, 4-cyano-CUMYL-BUTINACA, 4-CN-CUMYL BINACA, CUMYL-4CN-BINACA, SGT-78 (1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide) 7089 I
MDMB-4en-PINACA (methyl 3,3-dimethyl-2-(1-(pent-4- en-1-yl)-1H-indazole-3-carboxamido)butanoate) 7090 I N MDMB-4en-PINACA 7090 I
4F-MDMB-BUTICA (methyl 2-[[1-(4-fluorobutyl)indole-3- carbonyl]amino]-3,3-dimethyl-butanoate 7091 I
ADB-4en-PINACA (N-(1-amino-3,3-dimethyl-1- oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3- carboxamide) 7092 I
CUMYL-PEGACLONE (5-pentyl-2-(2-phenylpropan-2- yl)pyrido[4,3-b]indol-1-one) 7093 I
5F-EDMB-PICA (ethyl 2-[[1-(5-fluorophentyl)indole-3- carbonyl]amino]-3,3-dimethyl-butanoate 7094 I
MMB-FUBICA (methyl 2-(1-(4-fluorobenzyl)-1H-indole3-carboxamido)-3-methyl butanoate 7095 I
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) 7104 I
JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) 7118 I
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) 7122 I
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone 7144 I
JWH-073 (1-Butyl-3-(1-naphthoyl)indole) 7173 I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) 7200 I
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) 7201 I
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) 7203 I
NM2201, CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate 7221 I
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) 7222 I
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) 7225 I
4-methyl-alpha-ethylaminopentiophenone (4-MEAP) 7245 I N 4-MEAP 7245 I
N-ethylhexedrone 7246 I N 7246 I
Alpha-ethyltryptamine 7249 I
Ibogaine 7260 I
2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine) 7286 I
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) 7297 I
CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) 7298 I
Lysergic acid diethylamide 7315 I
2C-T-7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine 7348 I
Marihuana Extract 7350 I
Parahexyl 7374 I
Mescaline 7381 I
2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine ) 7385 I
3,4,5-Trimethoxyamphetamine 7390 I
4-Bromo-2,5-dimethoxyamphetamine 7391 I
4-Bromo-2,5-dimethoxyphenethylamine 7392 I
4-Methyl-2,5-dimethoxyamphetamine 7395 I
2,5-Dimethoxyamphetamine 7396 I
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) 7398 I
2,5-Dimethoxy-4-ethylamphetamine 7399 I
3,4-Methylenedioxyamphetamine 7400 I
5-Methoxy-3,4-methylenedioxyamphetamine 7401 I
N-Hydroxy-3,4-methylenedioxyamphetamine 7402 I
3,4-Methylenedioxy-N-ethylamphetamine 7404 I
3,4-Methylenedioxymethamphetamine 7405 I
4-Methoxyamphetamine 7411 I
Peyote 7415 I
5-Methoxy-N-N-dimethyltryptamine 7431 I
Alpha-methyltryptamine 7432 I
Bufotenine 7433 I
Diethyltryptamine 7434 I
Dimethyltryptamine 7435 I
Psilocybin 7437 I
Psilocyn 7438 I
5-Methoxy-N,N-diisopropyltryptamine 7439 I
4-chloro-alpha-pyrrolidinovalerophenone (4-chloro-aPV 7443 I
4´-methyl-alpha-pyrrolidinohexiophenone (MPHP 7446 I
N-Ethyl-1-phenylcyclohexylamine 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine 7458 I
1-[1-(2-Thienyl)cyclohexyl]piperidine 7470 I
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine 7473 I
N-Ethyl-3-piperidyl benzilate 7482 I
N-Methyl-3-piperidyl benzilate 7484 I
N-Benzylpiperazine 7493 I
4-MePPP (4-Methyl-alphapyrrolidinopropiophenone) 7498 I
2C-D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) 7508 I
2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) 7509 I
2C-H 2-(2,5-Dimethoxyphenyl) ethanamine) 7517 I
2C-I 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) 7518 I
2C-C 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) 7519 I
2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) 7521 I
2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) 7524 I
2C-T-4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine) 7532 I
MDPV (3,4-Methylenedioxypyrovalerone) 7535 I
25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) 7536 I
25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) 7537 I
25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) 7538 I
Methylone (3,4-Methylenedioxy-N-methylcathinone) 7540 I
Butylone 7541 I
Pentylone 7542 I
N-Ethypentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) 7543 I
alpha-pyrrolidinohexanophenone (a-PHP) 7544 I
alpha-pyrrolidinopentiophenone (α-PVP) 7545 I
alpha-pyrrolidinobutiophenone (α-PBP) 7546 I
Ethylone 7547 I
alpha-pyrrolidinoheptaphenone (PV8) 7548 I
Eutylone 7549 I
α-PiHP (4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1- one) 7551 I
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) 7694 I
Acetyldihydrocodeine 9051 I
Benzylmorphine 9052 I
Codeine-N-oxide 9053 I
Cyprenorphine 9054 I
Desomorphine 9055 I
Etorphine (except HCl) 9056 I
Codeine methylbromide 9070 I
Brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-4l)1,3-dihydro-2H-benzo[d]imidazol-2-one) 9098 I
Dihydromorphine 9145 I
Difenoxin 9168 I
Heroin 9200 I
Hydromorphinol 9301 I
Methyldesorphine 9302 I
Methyldihydromorphine 9304 I
Morphine methylbromide 9305 I
Morphine methylsulfonate 9306 I
Morphine-N-oxide 9307 I
Myrophine 9308 I
Nicocodeine 9309 I
Nicomorphine 9312 I
Normorphine 9313 I
Pholcodine 9314 I
Thebacon 9315 I
Acetorphine 9319 I
Drotebanol 9335 I
U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) 9547 I
AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) 9551 I
MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) 9560 I
Acetylmethadol 9601 I
Allylprodine 9602 I
Alphacetylmethadol except levo-alphacetylmethadol 9603 I
Alphameprodine 9604 I
Alphamethadol 9605 I
Benzethidine 9606 I
Betacetylmethadol 9607 I
Betameprodine 9608 I
Betamethadol 9609 I
Betaprodine 9611 I
Clonitazene 9612 I
Dextromoramide 9613 I
Isotonotazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) 9614 I
Diampromide 9615 I
Diethylthiambutene 9616 I
Dimenoxadol 9617 I
Dimepheptanol 9618 I
Dimethylthiambutene 9619 I
Dioxaphetyl butyrate 9621 I
Dipipanone 9622 I
Ethylmethylthiambutene 9623 I
Etonitazene 9624 I
Etoxeridine 9625 I
Furethidine 9626 I
Hydroxypethidine 9627 I
Ketobemidone 9628 I
Levomoramide 9629 I
Levophenacylmorphan 9631 I
Morpheridine 9632 I
Noracymethadol 9633 I
Norlevorphanol 9634 I
Normethadone 9635 I
Norpipanone 9636 I
Phenadoxone 9637 I
Phenampromide 9638 I
Phenoperidine 9641 I
Piritramide 9642 I
Proheptazine 9643 I
Properidine 9644 I
Racemoramide 9645 I
Trimeperidine 9646 I
Phenomorphan 9647 I
Propiram 9649 I
1-Methyl-4-phenyl-4-propionoxypiperidine 9661 I
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine 9663 I
2-Methyl AP-237 9664 I
Tilidine 9750 I
Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1Hbenzimidazol-1-yl)-N,N-diethylethan-1-amine) 9751 I
lunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5- nitro1H-benzimidazol-1-yl)ethan-1- amine) 9756 I
Metonitazene (N,N-diethyl-2-(2-(4- methoxybenzyl)-5- nitro-1Hbenzimidazol-1-yl)ethan-1-amine 9757 I
N-pyrrolidino etonitazene; etonitazepyne (2-(4-ethoxybenzyl)-5-nitro-1-(2- (pyrrolidin-1-yl)ethyl)- 1Hbenzimidazole) 9758 I
Protonitazene (N,N-diethyl-2-(5-nitro-2-(4- propoxybenzyl)-1H-benzimidazol-1- yl)ethan-1-amine) 9759 I
N-ETHYL-2-(2-(4-ISOPROPOXYBENZYL)-5-NITRO-1H- BENZIMIDAZOL-1-YL)ETHAN-1-AMINE 9760 I
2-(4-ETHOXYBENZYL)-5-NITRO-1-(2-(PIPERIDIN-1-YL)ETHYL)-1H-BENZIMIDAZOLE 9761 I
Metodesnitazene (N,N-diethyl-2-(2-(4- methoxybenzyl)- 1H-benzimidazol-1- yl)ethan-1-amine) 9764 I
Etodesnitazene; etazene (2-(2-(4-ethoxybenzyl)- 1Hbenzimidazol-1-yl)-N,N-diethylethan-1- amine) 9765 I
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) 9811 I
Para-Fluorofentanyl 9812 I
3-Methylfentanyl 9813 I
Alpha-methylfentanyl 9814 I
Acetyl-alpha-methylfentanyl 9815 I
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide 9816 I
Para-Methylfentanyl (N-(4-methylphenyl)-N-(1- phenethylpiperidin-4-yl)propionamide; also known as 4- methylfentanyl) 9817 I
4′-Methyl acetyl fentanyl (N-(1-(4- methylphenethyl)piperidin-4-yl)-N-phenylacetamide) 9819 I
ortho-Methyl methoxyacetyl fentanyl (2-methoxy-N-(2- methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide) 9820 I
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) 9821 I
Butyryl Fentanyl 9822 I
Para-fluorobutyryl fentanyl 9823 I
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) 9824 I
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide 9825 I
Para-chloroisobutyryl fentanyl 9826 I
Isobutyryl fentanyl 9827 I
Beta-hydroxyfentanyl 9830 I
Beta-hydroxy-3-methylfentanyl 9831 I
Alpha-methylthiofentanyl 9832 I
3-Methylthiofentanyl 9833 I
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) 9834 I
Thiofentanyl 9835 I
Beta-hydroxythiofentanyl 9836 I
Para-methoxybutyryl fentanyl 9837 I
Ocfentanil 9838 I
Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-Nphenylthiophene-2-carboxamide; also known as 2- thiofuranyl fentanyl;
thiophene fentanyl) 9839 I
Valeryl fentanyl 9840 I
Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-Nphenylbenzamide; also known as benzoyl fentanyl) 9841 I
beta′-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3- diphenylpropanamide; also known as β′-phenyl fentanyl; 3-phenylpropanoyl
fentanyl) 9842 I
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide 9843 I
Crotonyl fentanyl ((E-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide) 9844 I
Cyclopropyl Fentanyl 9845 I
ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)butyramide; also known as 2- fluorobutyryl
fentanyl) 9846 I
Cyclopentyl fentanyl 9847 I
ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1- phenethylpiperidin-4-yl)acetamide; also known as 2- methyl acetylfentanyl) 9848 I
Fentanyl related-compounds as defined in 21 CFR 1308.11(h) 9850 I
Fentanyl carbamate (ethyl (1-phenethylpiperidin-4- yl)(phenyl)carbamate) 9851 I
ortho-Fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)acrylamide) 9852 I
ortho-Fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)isobutyramide) 9853 I
Para-Fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)furan-2-carboxamide) 9854 I
2′-Fluoro ortho-fluorofentanyl (N-(1-(2- fluorophenethyl)piperidin-4-yl)-N-(2- fluorophenyl)propionamide; also known as 2′-fluoro
2- fluorofentanyl) 9855 I
beta-Methyl fentanyl (N-phenyl-N-(1-(2- phenylpropyl)piperidin-4-yl)propionamide; also known as β-methyl fentanyl) 9856 I
meta-Fluorofentanyl (N-(3-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)propionamide) 9857 I
meta-Fluoroisobutylryl fentanyl (N-(3-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)isobutyramide) 9858 I
para-Methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N- (1-phenethylpiperidin-4-yl)furan-2-carboxamide) 9859 I
3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-Nphenylfuran-3-carboxamide) 9860 I
2′,5′-Dimethoxyfentanyl (N-(1-(2,5- dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide) 9861 I
Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4- yl)-N-phenylbutanamide) 9862 I
ortho-Fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)furan-2-carboxamide) 9863 I
alpha′Methyl butyryl fentanyl (2-methyl-N-(1- phenethylpiperidin-4-yl)-N-phenylbutanamide) 9864 I
para-Methylcyclopropylfentanyl (N-(4-methylphenyl)-N- (1-phenethylpiperidin-4-yl)cyclopropanecarboxamide) 9865 I
Zipeprol (1-methoxy-3[-4-(2-methoxy-2- phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol) 9873 I
Phenmetrazine 1631 II
Methylphenidate 1724 II
Amobarbital 2125 II
Pentobarbital 2270 II
Secobarbital 2315 II
Glutethimide 2550 II
Dronabinol in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration 7365 II
Nabilone 7379 II
1-Phenylcyclohexylamine 7460 II
Phencyclidine 7471 II
ANPP (4-Anilino-N-phenethyl-4-piperidine) 8333 II
Norfentanyl (N-phenyl-N-(piperidin-4-yl) propionamide) 8366 II
Phenylacetone 8501 II
1-Piperidinocyclohexanecarbonitrile 8603 II
Alphaprodine 9010 II
Anileridine 9020 II
Coca Leaves 9040 II
Cocaine 9041 II
Etorphine HCl 9059 II
Dihydrocodeine 9120 II
Diphenoxylate 9170 II
Ecgonine 9180 II
Ethylmorphine 9190 II
Levomethorphan 9210 II
Levorphanol 9220 II
Isomethadone 9226 II
Meperidine 9230 II
Meperidine intermediate-A 9232 II
Meperidine intermediate-B 9233 II
Meperidine intermediate-C 9234 II
Metazocine 9240 II
Oliceridine (N-(3-methoxythiophen-2yl)methyl-9-(pyridin-2-yl)-6-oxaspiro[4.5] decan-9-yl] ethyl {time})amine fumarate) 9245 II
Metopon 9260 II
Dextropropoxyphene, bulk (non-dosage forms) 9273 II
Dihydroetorphine 9334 II
Opium tincture 9630 II
Opium, powdered 9639 II
Opium, granulated 9640 II
Noroxymorphone 9668 II
Phenazocine 9715 II
Thiafentanil 9729 II
Piminodine 9730 II
Racemethorphan 9732 II
Racemorphan 9733 II
Alfentanil 9737 II
Remifentanil 9739 II
Sufentanil 9740 II
Carfentanil 9743 II
Tapentadol 9780 II
Bezitramide 9800 II
Moramide-intermediate 9802 II

The company plans to import small quantities of the listed controlled substances to support research activities funded by
the National Institute on Drug Abuse. No other activities for these drug codes are authorized for this registration.

Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or non-approved
finished dosage forms for commercial sale.

Thomas Prevoznik, Deputy Assistant Administrator. [FR Doc. 2026-06311 Filed 3-31-26; 8:45 am] BILLING CODE P

There are no documents available to view or download

CFR references

21 CFR 1301.34(a)

Named provisions

Importer Registration - Controlled Substances

Get daily alerts for Regs.gov: Drug Enforcement Administration

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from DEA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
DEA
Published
March 3rd, 2026
Comment period closes
May 1st, 2026 (16 days)
Compliance deadline
May 1st, 2026 (16 days)
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
DEA-2026-0531
Docket
DEA-2026-0531

Who this affects

Applies to
Importers and exporters Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Controlled Substances Import Registration
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Compliance
Topics
Controlled Substances Healthcare

Get alerts for this source

We'll email you when Regs.gov: Drug Enforcement Administration publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!